| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |